Analysis: Sonoco Products (NYSE:SON) Stock Target Raised Today
In a comprehensive report announced by Barclays Capital on Wednesday morning, the firm, Sonoco Products (NYSE:SON), had their target PPS downgraded to $41.00. Analusts presently have a solid “Equal Weight” rating on the stock.
From a total of 10 analysts covering Sonoco Products Company (NYSE:SON) stock, 3 rate it a ”Buy”, 1 a “Sell”, and 9 a ”Hold”. This means that 23% of the ratings are positive. The highest target price is $50 while the lowest target price is $41. The mean of all analyst targets is $44.8 with a 5.19% above today’s ($43.73) stock price. Sonoco Products Company was the topic of 7 analyst reports since August 7, 2015 according to the firm StockzIntelligence Inc. Macquarie Research upgraded shares on November 23 to “Outperform” rating. Zacks downgraded SON stock in a recent report from September 7 to “Sell” rating.
Approximately 99,906 shares of stock traded hands. Sonoco Products Co (NYSE:SON) has declined 1.03% since April 29, 2015 and is downtrending. It has underperformed by 0.83% the S&P500.
Sonoco Products Company is a maker of industrial and consumer packaging products and a well-known provider of packaging services. The company has a market cap of $4.41 billion. The Firm operates in four divisions: Consumer Packaging, Paper and Industrial Converted Products, Display and Packaging, and Protective Solutions. It has 19.02 P/E ratio. The Firm has 335 locations in 33 countries.
According to Zacks Investment Research, “Sonoco is one of the world’s largest manufacturers of packaging materials for industrial and consumer markets. In addition, the company is one of the leading producers of recycled paperboard, utilizing more than a million tons of recovered paper annually in its papermaking operations. Sonoco products are used by many of the world’s leading industries, including food processing, beverages, textiles, supermarkets, plastics, papermaking, pharmaceuticals, material converting, material handling, agriculture, personal care, health care and many others.” Get a free copy of the Zacks research report on Sonoco Products Co (SON).